Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Ribbon Communications
RBBN
$383M
| $194K | ﹤0.01% |
32,429
+18,678
| +136% | +$126K |
|
|
ALTA
2702
DELISTED
Altabancorp
ALTA
| $194K | ﹤0.01% |
4,391
+2,115
| +93% | +$87.7K |
|
|
ZOM
2703
DELISTED
Zomedica Corp.
ZOM
| $194K | ﹤0.01% |
370,118
+177,858
| +93% | +$105K |
|
2704
Modine Manufacturing
MOD
$10.4B
| $193K | ﹤0.01% |
17,121
+10,163
| +146% | +$142K |
|
2705
First Financial Corp
THFF
$969M
| $192K | ﹤0.01% |
4,565
+2,210
| +94% | +$88.6K |
|
2706
Independent Bank Corp
IBCP
$844M
| $191K | ﹤0.01% |
8,881
+4,103
| +86% | +$85.4K |
|
|
ONTF
2707
DELISTED
ON24
ONTF
| $191K | ﹤0.01% |
9,565
+8,709
| +1,017% | +$242K |
|
|
AUTL
2708
Autolus Therapeutics
AUTL
$562M
| $190K | ﹤0.01% |
28,984
+7,647
| +36% | +$48.3K |
|
|
AERI
2709
DELISTED
Aerie Pharmaceuticals
AERI
| $190K | ﹤0.01% |
16,645
+8,790
| +112% | +$128K |
|
2710
i3 Verticals
IIIV
$342M
| $189K | ﹤0.01% |
7,817
+4,295
| +122% | +$124K |
|
2711
Oric Pharmaceuticals
ORIC
$1.4B
| $189K | ﹤0.01% |
9,046
+4,889
| +118% | +$99.1K |
|
|
FLIC
2712
DELISTED
First of Long Island Corp
FLIC
| $188K | ﹤0.01% |
9,173
+4,373
| +91% | +$91.9K |
|
2713
First Mid Bancshares
FMBH
$1.36B
| $187K | ﹤0.01% |
4,546
+2,620
| +136% | +$105K |
|
|
IGMS
2714
DELISTED
IGM Biosciences
IGMS
| $186K | ﹤0.01% |
2,847
+1,511
| +113% | +$116K |
|
2715
The RMR Group
RMR
$332M
| $186K | ﹤0.01% |
5,592
+3,082
| +123% | +$117K |
|
|
CPRX
2716
DELISTED
Catalyst Pharmaceutical
CPRX
| $185K | ﹤0.01% |
34,834
+19,493
| +127% | +$107K |
|
2717
TherapeuticsMD
TXMD
$24M
| $185K | ﹤0.01% |
4,993
+1,476
| +42% | +$65.5K |
|
|
PTVE
2718
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $185K | ﹤0.01% |
14,744
+8,753
| +146% | +$119K |
|
2719
Genco Shipping & Trading
GNK
$1.1B
| $183K | ﹤0.01% |
9,100
+5,370
| +144% | +$99.4K |
|
2720
Veru
VERU
$37.4M
| $182K | ﹤0.01% |
2,135
+1,239
| +138% | +$98.4K |
|
|
INBX
2721
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $182K | ﹤0.01% |
5,452
+1,824
| +50% | +$55.5K |
|
|
QUOT
2722
DELISTED
Quotient Technology Inc
QUOT
| $181K | ﹤0.01% |
31,184
+15,363
| +97% | +$129K |
|
2723
BioAtla
BCAB
$5.74M
| $179K | ﹤0.01% |
121
+96
| +384% | +$187K |
|
2724
Global Industrial
GIC
$1.49B
| $178K | ﹤0.01% |
4,689
+2,588
| +123% | +$97.2K |
|
2725
Standard BioTools
LAB
$314M
| $178K | ﹤0.01% |
27,015
+14,362
| +114% | +$94.5K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.